MARKET

TCBP

TCBP

TC BioPharm (Holdings) Ltd
NASDAQ
1.570
-0.010
-0.63%
Opening 15:34 04/23 EDT
OPEN
1.550
PREV CLOSE
1.580
HIGH
1.670
LOW
1.540
VOLUME
104.02K
TURNOVER
0
52 WEEK HIGH
32.00
52 WEEK LOW
0.8501
MARKET CAP
5.02M
P/E (TTM)
-0.0645
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TCBP last week (0415-0419)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Trevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. Mustang Bio stock increased by 11.97% and SINTX Techs stock rose 10.32% in the same session. Losers TRACON Pharma and DIH Holding US stock fell by 16.6% and 14.05% respectively.
Benzinga · 6d ago
Weekly Report: what happened at TCBP last week (0408-0412)?
Weekly Report · 04/15 10:29
BSGM, WAVE and TCBP among pre-market losers
U.S. Economy BSGM, WAVE and TCBP among pre-market losers. PainReform Ltd (PRFX) and Biosig Technologies (BSGM) lose 15% and 14%. Hexcel Corp. (HXL) names former Spirit AeroSystems head Gentile as new CEO.
Seeking Alpha · 04/10 12:22
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Etao International Co (NASDAQ:ETAO) stock moved upwards by 96.6% to $4.9 during Monday's regular session. Adlai Nortye stock rose 47.3% and Longeveron shares rose 48.63% during the session. Losers include Universe Pharmaceuticals, Agenus and Vincerx Pharma.
Benzinga · 04/08 16:31
Weekly Report: what happened at TCBP last week (0401-0405)?
Weekly Report · 04/08 10:32
Altice USA, Genfit, Brooge Energy among premarket losers' pack
On the Move: Altice USA, Genfit, Brooge Energy among premarket losers' pack. HWH International, ARCA biopharma, ZCMD, HWH among the biggest morning stock movers. ATUS, GNFT, BROG and HWH are among the morning's biggest losers.
Seeking Alpha · 04/05 12:29
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Protara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. Candel Therapeutic shares moved upwards by 25.93% during the session. The company's market cap stands at $236.5 million.
Benzinga · 04/05 12:09
More
About TCBP
TC BioPharm Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma-delta T cell therapies for the treatment of infectious disease. The Company's platform technology allows the Company to design specific therapies to treat a range of cancers and infectious diseases with off-the-shelf allogeneic gamma-delta T cell (GDT) products. The Company’s pipeline includes OmnImmune and CAR-T programs. OmnImmune is an unmodified allogeneic gamma-delta T cell product being used for the treatment of acute myeloid leukemia (AML). The Company has completed a Phase II clinical trial. Its CAR-T programs include in-house and partner programs at the pre-clinical-stage focused on developing CAR modified allogeneic gamma delta T-cell products targeting solid and hematological indications.

Webull offers TC BioPharm Ltd (ADR) stock information, including NASDAQ: TCBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCBP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCBP stock methods without spending real money on the virtual paper trading platform.